As a wholly owned subsidiary of Mitsubishi Corporation, Mitsubishi International Corporation (MIC) is a unique knowledge-based company.
Business Model: B2B
Revenue: $134.3B
Employees: 10,001-999,999
Address: 3-1, Marunouchi 2-Chome
City: Tokyo
State: tōkyō prefecture
Zip: 100-8086
Country: JP
As a wholly owned subsidiary of Mitsubishi Corporation, Mitsubishi International Corporation (MIC) is a unique knowledge-based company. Established in 1954 and headquartered in New York City, MIC offers a broad range of services to add value and create international business opportunities. Our primary businesses are: International trade involving commodities, consumer and industrial products Complex project management Strategic finance and investment These core businesses are organized into groups and business departments that cover such industries as aerospace, building &a; construction, chemicals, energy, foods, information communications &a; technology, life sciences, logistics, machinery, metals, packaging, printing &a; graphic arts, and textiles. Other important MIC business services are marketing and distribution, sourcing and transfer of technology as well as product sourcing and supply chain management. Headquartered in Tokyo, Mitsubishi Corporation is one of the world&s;s most diverse enterprises, with 804 subsidiaries and affiliates and a global network of 145 offices, 36 of which are in Japan. The company&s;s extensive network and wide-ranging activities give it a decisive edge in gathering the timely, accurate market information vital to the success of its customers and partners. Mitsubishi Corporation is one of many independent Mitsubishi companies. Founded in the early 1870&s;s, originally as a steamship company by Yataro Iwasaki, the Mitsubishi family of companies grew into a collection of companies engaged in most sectors of the Japanese economy. After World War II, the Mitsubishi holdings were broken up into over 40 independent companies, many of which still bear the Mitsubishi name and carry on its tradition of leadership and corporate principles.
Contact Phone:
Contact Email:
Announced Date | Company | Transaction | Money Raised |
---|---|---|---|
4/2002 | TradeBeam | Series B | 6M |
5/2005 | BioMimetic Therapeutics | Series C | 11.8M |
3/2007 | Informative | Venture Round | 0 |
12/2001 | Open Harbor | Series B | 10M |
10/2001 | NxtWave Communications | Series D | 0 |
11/2001 | Accelight Networks | Venture Round | 60M |
10/2000 | Mobileum | Series A | 0 |
1/2000 | Commerx Corp. | Series B | 0 |
12/2005 | NeurogesX | Series D | 20M |
10/2003 | OmniSonics Medical Technologies | Series C | 43M |
9/2006 | Anthera Pharmaceuticals | Venture Round | 0 |
6/2007 | Serenex | Series D | 0 |
3/2003 | BoostWorks | Series C | 9M |
5/2000 | SiRF Technology | Private Equity Round | 24.7M |
5/2001 | Quake Technologies | Series B | 30M |
10/2002 | Peninsula Pharmaceuticals | Series B | 0 |
10/2002 | NetLogic Microsystems | Venture Round | 32M |
10/2001 | Pixim | Series C | 0 |
7/2008 | Cara Therapeutics | Series C | 0 |
6/2001 | NxtPhase | Venture Round | 25M |
11/2004 | BioMimetic Therapeutics | Series C | 25.7M |
8/2008 | Anthera Pharmaceuticals | Venture Round | 0 |
3/2000 | Annuncio Software | Venture Round | 0 |
1/2008 | Sonexa Therapeutics | Series A | 0 |
7/2005 | Panacea Pharmaceuticals | Series C | 0 |
8/2008 | Anthera Pharmaceuticals | Venture Round | 0 |
7/2008 | Cara Therapeutics | Series C | 0 |
1/2008 | Sonexa Therapeutics | Series A | 0 |
6/2007 | Serenex | Series D | 0 |
3/2007 | Informative | Venture Round | 0 |
9/2006 | Anthera Pharmaceuticals | Venture Round | 0 |
12/2005 | NeurogesX | Series D | 0 |
7/2005 | Panacea Pharmaceuticals | Series C | 0 |
5/2005 | BioMimetic Therapeutics | Series C | 0 |
11/2004 | BioMimetic Therapeutics | Series C | 0 |
Name | Price |
---|
Name | Size | Announced Date |
---|